Search for a trial | Research with human participants

2 results

A Randomized Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Approved WMORecruitment stopped

To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with international prognostic scoring system (IPSS) low or intermediate-1 risk MDS as measured by the number of clinically significant bleeding events.

Stop TPO-receptor agonist in ITP Patients

Approved WMORecruitment stopped

Find/confirm percentage of remission after discontinuing TPO-RA in persistent and chronic ITP patients.